Liver Regeneration
15
4
4
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (15)
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy
Effect and Mechanism of ALPPS Operation on Liver Regeneration
To Study Effect of Injection Pentoxifylline on Liver Growth After Major Liver Surgery
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
Reversible Portal Vein Embolization Before Major Hepatectomy
Effect of Novel Donor Lifestyle Optimisation Protocol on Liver Regeneration in Live Liver Donors
Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome
ARAPS Study on Accelerated Liver Regeneration
Impact of Chemotherapy and Regenerative Markers of Liver Regeneration After Liver Resection for Liver Metastases
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
Platelets in Liver Regeneration
Study of the Protective Effect of Mechanism of Pentoxyfilline After Major Liver Resection Under Inflow Occlusion (Pringle Manoeuvre)
Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs
Registry of Major Liver Resections Including ALPPS and Other Liver Resections in Two Stages